Key result
This letter discusses the potential confounding role of preoperative frailty when assessing the association between treatment interval and survival in patients undergoing curative colon cancer surgery.
Why the study?
Does extending the interval between diagnosis and surgery affect cancer-free survival and overall survival in patients undergoing curative surgery for colon cancer?
Does extending the interval between diagnosis and surgery affect cancer-free survival and overall survival in patients undergoing curative surgery for colon cancer?
Answers are grounded in this paper and cite their sources.
This letter discusses the potential confounding role of preoperative frailty when assessing the impact of treatment intervals on survival in colon cancer surgery.
We read with great interest the study by Strous and colleagues evaluating the association between treatment interval, cancer-free survival (CFS), and overall survival (OS) among patients undergoing curative surgery for colon cancer [1]. The authors should be commended for addressing a clinically important question in geriatric oncology: whether extending the interval between diagnosis and surgery may provide a safe window for prehabilitation, particularly among patients at increased risk of postoperative complications.
No takes yet. Share an insight, caveat, or question.
Marín-López et al. (2026) conducted a letter in Colon cancer. Treatment interval before curative surgery was evaluated on Cancer-free survival (CFS) and overall survival (OS). This letter discusses the potential confounding role of preoperative frailty when assessing the association between treatment interval and survival in patients undergoing curative colon cancer surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: